Caricamento...
Trastuzumab cardiotoxicity: from clinical trials to experimental studies
Epidermal growth factor receptor‐2 (HER‐2) is overexpressed in 20 to 25% of human breast cancers, which is associated with aggressive tumour growth and poor prognosis. Trastuzumab (Herceptin®) is a humanized monoclonal antibody directed against HER‐2, the first highly selective form of therapy targe...
Salvato in:
| Pubblicato in: | Br J Pharmacol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5647179/ https://ncbi.nlm.nih.gov/pubmed/27714776 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13643 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|